NLS Pharmaceutics Challenges Nasdaq Delisting
Express News | NLS Pharmaceutics Announces Receipt of Staff Delisting Determination From Nasdaq; Intends to Request Hearing
NLS Pharmaceutics Ltd Strategizes for Growth
Board Member Resigns From NLS Pharmaceutics Ltd.
NLS Pharmaceutics Ltd. Announces New Warrant Issue
XTL Biopharmaceuticals XTLB Term Sheet; NLS Pharmaceutics NLSP Offering and Licensing Deal
NLS Pharmaceutics Ltd. Addresses Financial Claims
Express News | NLS Pharmaceutics Announces $1.75M Registered Direct Offering Of 7M Shares At $0.25/Share
NLS Pharmaceutics Expands Neurological Therapy Options
Express News | NLS Pharmaceutics Shares Are Trading Higher After the Company Announced an Exclusive Worldwide License Agreement With Aexon Labs, Which Grants the Company the Opportunity to Acquire Global Development and Commercialization Rights to Aexon's Dual Orexin Re
Express News | NLS Pharmaceutics Secures Exclusive Global License For Next-Generation Non-Sulfonamide Dual Orexin Agonist Platform
NLS Pharmaceutics Extends Loan Maturity Date
NLS Pharmaceutics to Participate in the BIO-EUROPE Springtime Partnering Event
ZURICH, SWITZERLAND / ACCESSWIRE / March 14, 2024 / NLS Pharmaceutics Ltd. (Nasdaq:NLSP)(Nasdaq:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company focused on the discove
Express News | NLS Pharmaceutics Has Been Notified By The Listing Qualifications Department Of The Nasdaq Stock Market That The Company's Plan To Regain Compliance Submitted On February 23, 2024 Has Been Approved
Nasdaq Accepts NLS Pharmaceutics' Plan to Regain Listing Compliance
Express News | NLS Pharmaceutics Says It Submited Plan To Regain Listing Compliance With Nasdaq
NLS Pharmaceutics Announced Nasdaq Letter Related To Continued Listing Requirements
NLS Pharmaceutics Announced Nasdaq Letter Related To Continued Listing Requirements
NLS Pharmaceutics CEO Issues Letter to Shareholders
NLS Pharmaceutics Ltd. (NASDAQ:NLSP, NLSPW) today announces that its Chief Executive Officer, Alex Zwyer, has issued the following letter to shareholders.
Sector Update: Health Care Stocks Rise in Afternoon Trading
Health care stocks rose Friday afternoon with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) each adding 0.3%. The iShares Biotechnology ETF (IBB) was up 0.7%. In corpora
Top Midday Gainers
Bit Brother (BETS) said it has purchased 3,300 units of Antminer S19 miners to boost its mining operations. Shares of the company surged 28%, with over 175 million shares traded intraday compared with
No Data